Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
Abstract
The outbreak of coronavirus (SARS-CoV-2) disease caused more than 100,000,000 people get infected and over 2,200,000 people being killed worldwide. However, the current developed vaccines or drugs may be not effective in preventing the pandemic of COVID-19 due to the mutations of coronavirus and the severe side effects of the newly developed vaccines. Chinese herbal medicines and their active components play important antiviral activities....
Paper Details
Title
Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
Published Date
Jul 1, 2021
Journal
Volume
87
Pages
153591 - 153591
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History